BPC-157 Pen 5 mg
5mg99,00 € incl. VAT
BPC-157 Pen 5 mg: pre-filled pen with BPC-157 (synthetic 15-amino-acid peptide) as a ready-to-use solution, 5 mg in a 2 mL cartridge (2.5 mg/mL). No reconstitution: the dial sets a fixed volume per click. The substance is independently tested by HPLC and the Certificate of Analysis is published on this page. For laboratory research use only.
Pre-order
Shipping from 11,93 € · Free EU shipping over 200 €
📋 View the Certificate of Analysis information
Product specifications
| Quantity | 5mg |
|---|---|
| Unit | 1 pre-filled pen |
| Purity data | 99.6% (batch XD-BC5-PO06) |
| Format | Pre-mixed pen (solution in cartridge) |
| Volume | 2 mL solution |
| Concentration | 2.5 mg/mL |
| Storage | 2–8 °C, protected from light |
| Source lot | XD-BC5-PO06, tested by Liquilabs |
Description
Research use only. Sold for laboratory research. Not a medicine, and not for human or veterinary use.
Pre-order
This pen is being prepared for its first production run. Orders placed now are reserved and ship as soon as stock arrives; you will get an email with tracking the day it leaves.
What is BPC-157?
BPC-157 ("Body Protection Compound") is a synthetic peptide of 15 amino acids, derived from a protective protein found in human gastric juice. It is unusually stable for a peptide and has been studied for more than thirty years, almost entirely in animals.
What the research shows
- Tendon and ligament. In rat models of Achilles tendon and medial collateral ligament injury, treated animals healed faster and regained more strength.
- Muscle and bone. Faster recovery after muscle crush injury and improved healing of bone defects in animal studies.
- Gut. Protection against ulcers and faster healing of intestinal lesions and fistulas in rodents, the area where the peptide was first studied.
- Blood vessels. It promotes the formation of new vessels, linked to the VEGFR2 pathway and nitric-oxide signalling (Hsieh et al., 2017).
- Nervous system. Protective effects in animal models of nerve and brain injury.
Side effects reported in studies
Animal toxicology studies found no clear toxic dose. Human safety data are very limited: a few small pilot studies and no large controlled trial. It is on the WADA prohibited list.
Doses reported in published studies
There is no established human dose. Animal studies most often use 10 micrograms or 10 nanograms per kilogram of body weight per day, given by injection or in drinking water.
This section summarises the doses used in the published literature. It is not a recommendation.
About the pre-mixed pen format
A pre-mixed pen holds the peptide already reconstituted inside a sealed cartridge, so there is no vial to open, no solvent to measure and no transfer step. The solution stays in a closed system from filling to use, and the dial delivers the same volume on every click. Each pen is filled from a lot of lyophilised substance that has already been through independent testing; the lot number is shown on this page.
Supplied as one pre-filled pen, without other accessories.
Pen or vial?
| Pen | Vial | |
|---|---|---|
| Form on arrival | Solution in a cartridge (dual-chamber: powder and solvent, mixed on activation) | Lyophilised powder |
| Reconstitution | Not needed | Done by the user with bacteriostatic water |
| Measuring | Dial, fixed volume per click | Syringe, calculated per draw |
| Handling steps | One | Several |
| Price per mg | Higher | Lower |
| Best for | Convenience and repeatable volumes | Lowest cost and the longest unopened shelf life |
Prefer the lyophilised vial? See BPC-157 5mg.
Storage
Keep the pen refrigerated at 2–8 °C, in its box and away from light. Do not freeze. Do not use if the solution is cloudy, discoloured or contains particles. Short temperature excursions during shipping are expected and are covered by insulated packaging.
Quality and Certificate of Analysis
The substance in this pen comes from lot XD-BC5-PO06, tested by Liquilabs, an independent laboratory: 99.6% purity by HPLC, with identity confirmed and endotoxin and heavy metals tested on the same report. The report is published in our lab reports archive, and the lot number can be checked on the laboratory's own site. The certificate describes the lyophilised source lot; the finished solution in the pen has not been analysed separately.
Frequently asked questions
When will my pre-ordered BPC-157 Pen 5 mg ship?
As soon as the first production run arrives. You receive tracking by email on the day it leaves.
Does the BPC-157 Pen 5 mg need to stay cold?
Yes. Keep it at 2–8 °C. It ships in insulated packaging.
What does the Certificate of Analysis cover?
The lot of lyophilised substance the pen was filled from. The finished solution in the pen has not been analysed separately.
What is in the box?
One pre-filled pen. Needles and other accessories are not included at the moment.
Is it the same substance as the vial?
Yes. It is the same substance in a different format.
Batch test records
The substance in this pen comes from the lot below. The report describes the lyophilised source lot; the finished solution in the pen has not been analysed separately.
- Tested
- October 1, 2026
- Assay
- Purity, Endotoxin, Heavy metals
- Purity
- 99.6%
You Might Also Like
GHK-Cu Pen 50 mg: pre-filled pen with GHK-Cu (copper tripeptide) as a ready-to-use solution, 50 mg in a 2 mL cartridge (25 mg/mL). No reconstitution: the dial sets a fixed volume per click. The substance is independently tested by HPLC and the Certificate of Analysis is published on this page. For laboratory research use only.
- Purity tested
- Endotoxin tested
- Heavy metals tested
GLP-3 (Retatrutide) Pen 10 mg: pre-filled pen with retatrutide (triple GIP/GLP-1/glucagon receptor agonist) as a ready-to-use solution, 10 mg in a 2 mL cartridge (5 mg/mL). No reconstitution: the dial sets a fixed volume per click. The substance is independently tested by HPLC and the Certificate of Analysis is published on this page. For laboratory research use only.
- Purity tested
- Endotoxin tested
- Heavy metals tested
GLP-3 (Retatrutide) Pen 20 mg Dual-Chamber: dual-chamber pen with 20 mg of lyophilised retatrutide (triple GIP/GLP-1/glucagon receptor agonist) and 1 mL of water in separate chambers of one cartridge. Activation mixes them to 20 mg/mL, so the peptide ships and stores as a dry powder. Certificate of Analysis coming soon. For laboratory research use only.
NAD+ Pen 500 mg: pre-filled pen with NAD+ (nicotinamide adenine dinucleotide) as a ready-to-use solution, 500 mg in a 2 mL cartridge (250 mg/mL). No reconstitution: the dial sets a fixed volume per click. The substance is independently tested by HPLC and the Certificate of Analysis is published on this page. For laboratory research use only.
- Purity tested
- Endotoxin tested
PT-141 Pen 10 mg: pre-filled pen with PT-141 (bremelanotide, melanocortin receptor agonist) as a ready-to-use solution, 10 mg in a 2 mL cartridge (5 mg/mL). No reconstitution: the dial sets a fixed volume per click. The substance is independently tested by HPLC and the Certificate of Analysis is published on this page. For laboratory research use only.
- Purity tested
- Endotoxin tested
TB-500 Pen 5 mg: pre-filled pen with TB-500 (synthetic peptide derived from thymosin beta-4) as a ready-to-use solution, 5 mg in a 2 mL cartridge (2.5 mg/mL). No reconstitution: the dial sets a fixed volume per click. The substance is independently tested by HPLC and the Certificate of Analysis is published on this page. For laboratory research use only.
- Purity tested
- Endotoxin tested
- Heavy metals tested
Tirzepatide Pen 10 mg: pre-filled pen with tirzepatide (dual GIP/GLP-1 receptor agonist) as a ready-to-use solution, 10 mg in a 2 mL cartridge (5 mg/mL). No reconstitution: the dial sets a fixed volume per click. The substance is independently tested by HPLC and the Certificate of Analysis is published on this page. For laboratory research use only.
- Purity tested
- Endotoxin tested
- Heavy metals tested
